Efficacy indicators of four methods in outpatient addiction treatment by Andreia de Moura et al.
Original article
Address for correspondence: Andreia de Moura. Universidade Lusófona do Porto Faculty of Psychology, Education and Sports. Rua Augusto Rosa, 24 – 4000-098 – Porto, Portugal. 
E-mail: andreiamoura7@gmail.com
Efficacy indicators of four methods in outpatient addiction treatment 
AndreiA de MourA1, ricArdo Pinto1, LígiA Ferros2, inês JongeneLen1, Jorge negreiros3
1 Universidade Lusófona do Porto, Porto, Portugal.
2 Universidade Lusíada do Porto, Porto, Portugal.
3 Universidade do Porto, Faculdade de Psicologia e de Ciências da Educação, Porto, Portugal. 
Received: 04/17/17 – Accepted: 08/15/2017
DOI: 10.1590/0101-60830000000134
Abstract
Background: In Portugal, as far as we know, there are no recent studies that evaluated the comparative efficacy of therapeutic modalities in addiction problems 
by reference to a holistic and psychosocial model of effectiveness. Objectives: Using a sample of Portuguese patients in outpatient treatment for drug and 
alcohol abuse, this study aimed to examine if a combined treatment modality (group therapy with individual intervention) had greater overall efficacy when 
compared to other three types of treatment without group therapy. Methods: This is a correlational and cross-sectional study using a convenience sample of 
patients (N = 254) from an outpatient treatment in the Intervention Service on Addictive Behaviors and Substance Dependence. At the time of data collection, 
the patients were attending four types of treatment, such as receiving intervention based on individual psychological counseling (n = 66); receiving individual 
psychiatric counseling (n = 68); receiving both individual psychological and psychiatric counseling (n = 102); and receiving not only individual counseling (i.e., 
psychology or psychiatry), but also attending group therapy (n = 18). Results: Using MANOVA and Wilks’s multivariate test criterion, there was a significant 
effect of treatment modality on the global efficacy, Λ = 0.88, F(9, 603) = 3.75, p < 0.0001. Examination of mean estimates indicated that patients in a combined 
therapeutic modality revealed more treatment involvement compared to patients in other therapeutic modalities without group therapy. Discussion: The 
results obtained in this study highlight the importance of integrating interventions in a collaborative way. A combined therapeutic modality, adding group 
therapy, was associated with positive effects, such as more levels of peer support and involvement in treatment, and increasing the individual’s probability to 
remain abstinent. 
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Introduction
Outpatient treatments for drug or alcohol dependence can include a 
variety of treatment methods, such as individual or group therapy. The 
literature suggests that these specific types of treatment are more effective 
as more they take into account the diversity and the patients’ deficit areas, 
through an eclectic and systematic approach1. It is not just a question 
of finding a good match between patient and treatment modality2, but 
of acting in a concerted manner upon the various deficit areas of the 
patient3,4. It is an established fact in the scientific community that a 
combined and integrated treatment by itself increases the likelihood of 
obtaining better results not only in addiction problems3,4, but also in 
various treatments for mental disorders1.
However, some studies suggest that certain therapies and therapy 
combinations in treatment programs seem to increase the success of 
interventions in the treatment of addiction. This is the case of group 
therapy that has been considered by some authors as the intervention 
of choice in the treatment of addictions5,6. Group therapy increases the 
perception of better peer support, being a privileged tool of persuasion, 
stabilization and social support in the treatment of addiction7. The 
positive social support and peer support help to maintain abstinence8, 
and improve treatment outcomes9. Group therapy has also been 
associated with the effectiveness of the treatment in psychological 
distress symptoms10,11 and has been found to be effective in reducing 
the negative affects12. Additionally, group therapy also provides social, 
emotional, and relational skills in order to increase their perception of 
being accepted and accept others, as well as dealing with emotional states 
in the relationship with others13. Some factors that arise from the group 
therapy include catharsis, cohesion, interpersonal learning14, affiliation, 
confrontation, support, gratification, and identification, which seem to 
promote the involvement of patients in their treatment5,15, and promote 
a better prognosis16. These factors promoted by group therapy increase 
the success of interventions, not only in the addiction problems, but 
also in psychotherapy in general17. 
Given the advantages of group therapy, some studies 
specifically seek to understand if a combined modality of 
individual and group therapy would increase the probability 
of success of treatment programs. In fact, some literature 
corroborates this view stating that group therapy and individual 
therapy seem to complement each other in addiction treatment. 
The patients appear to be more likely to remain engaged in their 
recovery process if they have been involved in group therapy15. 
In this sense, some authors confirm that a combined intervention 
of an intensive individual counseling (individual drug counseling 
– IDC) added to group counseling (group drug counseling – 
GDC) increases the likelihood of effective treatment in cocaine 
dependence, raising abstinence rates18. 
However, as far as we know, there are no studies in Portugal 
that have evaluated the comparative efficacy of therapeutic 
modalities by reference to a holistic and psychosocial model of 
effectiveness. Considering the previous discussion, this study 
aimed to examine, in a sample of Portuguese patients in outpatient 
treatment for drug and alcohol abuse, if a combined treatment 
modality (group therapy with individual intervention) had better 
outcomes, when compared to other three types of treatment 
without group therapy: group receiving intervention based on 
individual psychological counseling; group receiving intervention 
based on individual psychiatric counseling; and group receiving 
intervention based on individual psychological and psychiatric 
counseling. The groups were compared in terms of some indicators 
of efficacy that are described in the literature19 (i.e., abstinence, 
involvement in treatment, social and peer support, psychological 
distress symptoms and negative affects). We expected that patients 
who attended the combination of both individual and group 
therapies reported lower rates of psychological distress symptoms 
and negative affects, as well as higher rates of abstinence, 
involvement in treatment, and social and peer support, than other 
patients involved in individual therapies. 
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Methods
Participants
The present study is part of a larger research project funded by 
Fundação para a Ciência e Tecnologia (Foundation for Science and 
Technology – Portuguese and European funding) on the study of 
608 Portuguese patients in treatment for drug addiction and alcohol 
abuse. For this study, as inclusion criteria, the participants had to be 
on outpatient alcohol and drug treatment (including the attending 
of at least one of the four treatments described below) and age over 
18 years old. Exclusion criteria were having apparent psychosis, 
intoxication, or having mental retardation, in order to ensure 
that informed consent could be given. The participants who meet 
these criteria were 254 patients, male (85.8%) and female (14.2%) 
with ages range from 18 to 73 years; mean age for the sample was 
41.58 (SD = 8.71), recruited from outpatient treatment programs 
at the Intervention Service on Addictive Behaviors and Substance 
Dependence (SICAD) - Regional Northern Section. There were no 
differences between the included vs. excluded participants in terms of 
age (t(603) = 1.65, p = 0.099) and gender (χ2(1) = 0.340, p = 0.56). At 
the time of the data collection (between January 2012 and May 2013), 
the participants were attending different four types of treatment for 
drug and alcohol, such as receiving intervention based on individual 
psychological counseling (n = 66) (therapeutic modality I), where 
92.4% of this subsample was men, with ages ranging from 20 to 
56 years (M = 41.09; SD = 7.08); receiving individual psychiatric 
counseling (n = 68) (therapeutic modality II), where 77.9% of this 
subsample was men, with ages ranging from 28 to 56 years (M = 41.96; 
SD = 6.85); receiving both individual psychological and psychiatric 
counseling (n = 102) (therapeutic modality III), where 88.2% of 
this subsample was men, with ages ranging from 18 to 66 years 
(M = 40.88, SD = 10.24); and receiving not only individual counseling 
(i.e., psychology or psychiatry), but also attending group therapy 
(n = 18) (therapeutic modality IV), which 77.8% of this subsample 
was men, with ages ranging from 33 to 73 years (M = 45.94, SD = 
24.10). This was a cross-sectional and correlational study with a 
convenience sample, which no randomization of the participants 
by groups was made. The group treatment allocation was performed 
after the data collected considering the type of treatment that the 
patients were receiving. Further details about the descriptive analysis 
and the homogeneity of the 4 groups can be found in Table 1. 
Measures
A Socio-Demographic Questionnaire20,21 collected information 
about gender, age, birthplace, treatment program, primary substance 
of abuse, treatment time, pattern of substance use and abstinence. 
The outcome variable abstinence was operationalized as follows: 
dichotomous variable (“absence of substance use” = 0 and “substance 
use” = 1) defined in terms of the presence vs. absence of substance use 
during treatment. The minimum time during which the individual 
restrained from using substances was of at least 1 month. 
Brief Symptoms Inventory (BSI)22. This is a reduced version 
of the Symptom Check List 90 Revised (SCL-90-R), a self-report 
inventory consisting of 53 items. The individual must specify the 
degree to which each problem has affected them over the past 
week, on a Likert-type scale (1-Never, 2-Rarely, 3-Sometimes, 
4-Often, 5-Very often). This inventory assesses psychological distress 
symptoms along nine basic dimensions (somatization, obsession-
compulsion, interpersonal sensitivity, depression, anxiety, hostility, 
phobic anxiety, paranoid ideation and psychoticism) and three global 
indices (positive symptoms distress index – PSDI, global severity 
index – GSI, and positive symptom total – PST). In the current study, 
the various dimensions have an internal consistency ranging from 
moderate to high, with Cronbach’s alpha values between 0.67 to 0.86. 
The internal consistency of the overall BSI in this sample was 0.96.
Monitoring and Evaluation of Effectiveness and Progress 
(MEEP) –Portuguese short form20,21. A short Portuguese measure 
(MEEP) with psychometric qualities demonstrated21, covers 4 
overall factors and 22 items: (a) Therapeutic Progress subscale 
(α = 0.88) – includes items intended to measure treatment 
engagement, treatment satisfaction and counselling rapport; 
(b) Negative Affects subscale (α = 0.81) – includes items that 
measure the psychological functioning; (c) Social support subscale 
(α = 0.83) – seeks to measure the perception of social support 
received; and (d) Peer support scale (α = 0.85) – includes items 
that measure the perception of social support received by peers. 
On average, it takes 15-20 minutes to complete the questionnaire 
properly. The response format is a 7-point Likert scale (1 – I strongly 
disagree to 7 – I strongly agree). The internal consistency of the overall 
MEEP-22 in this sample was .81.
Global Efficacy Measure was defined by a composite variable 
that included 3 components – absence of substance abuse (defined 
in terms of the absence or presence of substance abuse during 
treatment), psychological distress symptoms below the cutoff 
(ISP < 1.7) and high levels of involvement in treatment (PT ≥ 6). 
These different components were evaluated through the Socio-
Demographic Questionnaire20,21; the Positive Symptoms Index (PSI) 
from BSI (Portuguese version of Canavarro, 1999)22 and the MEEP20,21  
based on TCU-CEST23. Higher scores reflect higher indicators of 
treatment efficacy. 
Procedure
A formal contact with SICAD was established to obtain permission 
to conduct the investigation, as well as with the ethics committee 
of the Faculty of Psychology and Education Sciences (University 
of Porto). Professionals of these institutions made the first contact 
with the participants, where a general explanation of the study 
was provided to them, and then they were asked if they agreed to 
participate in the study. Written and verbal consent were obtained 
from each participant. To ensure the confidentiality of all participants, 
their names and personal information have been coded. The 
questionnaires were administered in an interview format by trained 
female psychologists at the facilities of SICAD (Regional Northern 
Delegation), in a private and quiet room. 
Data analysis
Data analyses were carried out using the SPSS version 18 for Windows 
(United States, New York, IBM Corporation). Descriptive statistics 
were calculated to characterize the study variables. We used Chi-
square analyses to examine differences among groups in terms of 
the dependent variable abstinence and Kruskal-Wallis test to explore 
differences among groups in terms of treatment retention. We 
used MANOVA and Wilks’s multivariate test criterion to examine 
differences among groups in terms of the dependent variables 
treatment involvement, negative affects, psychological distress 
symptoms, social support, and peer support. Pearson correlation 
analyses was conducted previously to verify if the dependent variables 
were correlated among them. Finally, we used a Mann-Whitney test 
to confirm the findings from MANOVA due to the lack of normal 
distribution to conduct parametric tests, with a Bonferroni correction 
by reducing the p value to < 0.0125, adjusted for four groups. 
Results
Further details about the descriptive analysis can be found in Table 1. 
Chi-square analyses revealed no significant associations between 
the four intervention modalities in terms of previous severity of 
the addiction (χ² = 7.94, p = 0.242). Kruskal-Wallis test revealed 
no significant differences between groups in terms of treatment 
retention, χ²(3) = 2.62, p = 0.454. Considering the time interval 
between sessions, this interval ranged from weekly to monthly for all 
individual therapeutic modalities I, II and III (69% to 87% of cases). 
In combined therapeutic modality IV, this percentage was 75% of 
119Moura A et al. / Arch Clin Psychiatry. 2017;44(5):117-21
cases. Chi-square analyses also revealed that patients in therapeutic 
modality I reported less drug therapy (42%, n = 27), compared to 
patients in therapeutic modality IV (77.8%, n = 14), therapeutic 
modality II (65.7%, n = 44), and therapeutic modality III (58%, 
n = 57) (χ² = 11.02, p = 0.012). 
Chi-square analyses shown that patients in therapeutic modality 
IV significantly reported more abstinence (78%; n = 14) than patients 
in other treatment program modalities, including therapeutic 
modality III (56%; n = 57), therapeutic modality II (55%; n = 37), and 
therapeutic modality I (42%; n = 27), (χ² = 8.34, p < 0.05). Pearson 
correlation analyses showed that peer support was significantly 
correlated with social support (r = 0.19, p = 0.002). Treatment 
involvement was significantly correlated with social support 
(r = 0.49, p < 0.0001), and peer support (r = 0.13, p = 0.03), but was 
not significantly correlated with negative affects (r = -0.02, p = 710). 
Negative affects was also not significantly correlated with peer support 
(r = -0.02, p = 740). Similarly, psychological distress symptoms was 
not significantly correlated with treatment involvement (r = -0.09, 
p = 0.13), and peer support (r = -0.02, p = 70). Considering these 
results, the variables negative affects and psychological distress 
symptoms were not included in multivariate analyses.  
Using MANOVA and Wilks’s multivariate test criterion, there 
was a significant effect of treatment modality on the global efficacy, 
Λ = 0.88, F(9, 603) = 3.75, p < 0.0001. Univariate tests showed 
statistically significant effects for treatment involvement (F(3,254) 
= 5.04, p = 0.002) and also peer support (F(3,254) = 6.15, 
p < 0.001). Examination of mean estimates indicated that patients 
in therapeutic modality IV revealed more treatment involvement 
(M = 52.89; SD = 2.93) than patients in therapeutic modalities I 
(M = 48.3; SD = 5.56) and II (M = 47.69; SD = 6.61). There were 
no significant differences between patients in therapeutic modality 
IV and patients in therapeutic modality III (p = .23). The patients 
in therapeutic modality IV also revealed more peer support 
(M = 9.56; SD = 3.24) compared to patients in therapeutic modalities 
II (M = 6.75; SD = 3.61), and I (M = 5.63; SD = 3.68). There were no 
significant differences between patients in therapeutic modality IV 
and patients in therapeutic modality III (p = 0.06).
We verified that all nonparametric analyses confirmed the 
multivariate analyses, with exception of the differences between 
therapeutic modality IV and therapeutic modality III in terms of 
peer support. Particularly, in terms of treatment involvement, the 
therapeutic modality IV was significantly different from therapeutic 
modalities I (U = 292.00, p = 0.001) and II (U = 326.00, p = 0.002), 
as well as the therapeutic modality IV was significantly different 
from therapeutic modalities I (U = 251.00, p < 0.0001) and II 
(U = 319.50, p = 0.002), in terms of peer support. Regarding the 
treatment involvement, there were no significant differences between 
patients in therapeutic modality IV and patients in therapeutic 
modality III (U = 640.00, p = 0.04). However, considering the peer 
support, significant differences were found between patients in 
modality IV and patients in modality III (U = 534.00, p = 0.004). 
Patients in modality IV revealed more peer support (Mean Rank = 
81.81) than patients in modality III (Mean Rank = 56.74). 
Discussion
This study aimed to compare a combined treatment modality, 
including individual counseling and group therapy, with other three 
treatment modalities without group therapy, in terms of efficacy 
indicators among Portuguese patients in outpatient treatment for 
drug and alcohol abuse. According to the results, we confirmed 
our hypothesis regarding the efficacy indicators of abstinence, 
involvement in treatment, and peer support. Specifically, we 
found that patients engaged in therapeutic modality IV (attending 
individual and group therapy) showed significantly better therapeutic 
involvement than patients in therapeutic modality I (psychological 
counseling) and therapeutic modality II (psychiatric counseling). 
Comparatively to individual therapeutic modalities (I and II), the 
therapeutic modality IV seems to have clear advantages in terms 
of patient involvement in treatment. These results were expected 
since this view is corroborated in literature, stating that group 
therapy and individual therapy seem to complement each other in 
addiction treatment15. The patients appear to be more likely to remain 
engaged in their recovery process if also have been involved in group 
Table 1. Descriptive statistics of the sample 
Therapeutic Modality I
(n = 66)
Therapeutic Modality II
(n = 68)
Therapeutic Modality III
(n = 102)
Therapeutic Modality IV
(n = 18)
Psychophathology symptoms in time of questionnaire administration (%)
(≥ 1.7) (%) 63.6 60.3 55.9 55.6
Treatment retention (months)
M 29.81 29.52 26.35 30.79 
SD 21.04 23.86 21.93 17.1
Comsumption patterns in time of questionnaire administration (%)
Abstinence 41.6 55.2 55.9 77.8
Recreational use 35.4 28.4 18.6 22.2
Regular use 16.9 9.0 12.7 0.0
Substance abuse 4.6 6.0 7.8 0.0
Dependence 1.5 1.4 4.9 0.0
Comsumption patterns prior to treatment (%)
Regular use 0.0 1.5 2.0 0.0
Substance abuse 3.1 13.8 14.7 16.7
Dependence 96.9 84.7 83.3 83.3
Primary substance of abuse
Heroine 51.5 26.5 34.4 11.1
Cocaine 4.5 22.1 17.6 5.6
Alcohol 4.5 19.1 28.4 83.3
Hashishe 1.5 0.0 2.9 0.0
Polydrug use 38.0 32.3 15.7 0.0
Psychopharmacotherapy 0.0 0.0 1.0 0.0
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therapy15. Group therapy is indeed considered by some authors as 
the intervention of choice in the treatment of addictions5,6, given that 
several aspects are strengthened, particularly the catharsis, group 
cohesion, interpersonal learning14, affiliation, confrontation, support, 
gratification, and identification15. These aspects seem to promote the 
involvement of patients in their treatment5,15, which in turn increase 
the likelihood of better patient prognosis16. 
Moreover, it is possible that patients who have attended a 
multimodal treatment (individual and group therapy) had felt more 
valued for having received more assistance and/or a better service, 
thus increasing their satisfaction with treatment and therapeutic 
involvement. In fact, according to a conceptual heuristic model 
oriented to the addiction area24,25, the involvement in treatment 
implies some essential aspects, as therapeutic relationship, 
satisfaction with the treatment, participation and treatment 
compliance26,27. This hypothesis seems to be supported by the fact 
that there were no differences between therapeutic modality IV and 
therapeutic modality III (individual counseling in both Psychology 
and Psychiatry). Indeed, both the combined treatment modalities (III 
and IV) add at least two complementary and concerted interventions 
in the same treatment program. The inclusion of two complementary 
interventions directed to the patients’ deficit areas can promote a 
positive effect in treatment outcomes3,4, specifically in the patient’s 
involvement in treatment. 
As hypothesized, the patients in treatment modality IV reported 
more positive peer support compared to the patients from the other 
individual therapeutic modalities (I and II). This result is consistent 
with empirical evidence showing that treatment modalities with 
group therapy increase the perception of better peer support7, being 
privileged ways of persuasion, stabilization and social support in the 
treatment of addiction7. Actually, one of the central goals of group 
therapy is to increase in patients the perception of being accepted 
and accept others, and to deal with emotional states in interpersonal 
relationships13. In the addictions area, the promotion of positive 
social and peer support increases the likelihood of success in 
interventions, helping to maintain abstinence8 and to obtain better 
treatment results9.
Additionally, our hypothesis was confirmed because patients 
engaged in therapeutic modality IV reported significantly better 
results in terms of abstinence than those who had attended in any of 
the other treatment modalities, consistent with literature previously 
discussed14,18. In general, in the area of mental health, empirical 
evidence has shown that treatment protocols which include group 
therapy, particularly cognitive behavioral therapy, are more effective 
compared to other treatment modalities12,18. Considering that this 
treatment modality (adding group therapy) was associated with 
better results in terms of involvement in treatment and positive peer 
support and these factors have been associated with better treatment 
outcomes16,9,15, it was also expected that abstinence would be higher 
in this group. 
Finally, this study also confirms the results of a previous study 
showing that a combined intervention of an intensive individual 
counseling (individual drug counseling – IDC), added to group 
counseling (group drug counseling – GDC), increased the likelihood 
of effective treatment in cocaine dependence, raising abstinence 
rates18. According to the authors of this study, these two combined 
interventions may have focused their similar goals in the maintenance 
of abstinence, boosting the effect of both interventions18. 
Limitations
First, this is a cross-sectional study, which is not the best method 
to assess treatment efficacy because the participants were not 
randomly allocated to the group treatments and we have not pre-test 
data. Therefore, we cannot guarantee the homogeneity in terms of 
outcome variables among groups before the treatments. For instance, 
we have no data about the patients´ health status at the time of the 
admission to treatment (e.g., psychological distress symptoms and 
negative affects). These limitations reduce the internal validity of 
the study when groups are compared in terms of outcome variables, 
and any causality relationships between the variables under study 
must be interpreted with care. Additionally, this research focuses 
on patients with different types of dependence, from either drugs 
or alcohol, which can be considered a limitation because increase 
the heterogeneity of the sample. Finally, we did not assess marital 
status and income and they are important markers of treatment 
effectiveness. 
Conclusions
Despite the limitations, the contribution of this study focus on 
the novelty in testing a psychosocial model that conceptualizes 
the effectiveness of dependence treatments, identifying specific 
therapeutic modalities that best enhance these predictive factors 
of therapeutic success. It is known that most studies only use 
abstinence as an effective treatment criterion, or psychological and 
social variables alone, and not in an integrated manner. As far as 
we know, there are no studies in Portugal and Brazil that evaluated 
the comparative efficacy of therapeutic modalities by reference to 
a holistic and psychosocial model of effectiveness. The results of 
this study suggest the importance of integrating interventions in 
a collaborative way, showing that individual and group therapies 
are not mutually exclusive and that they should be integrated. A 
combined therapeutic modality, adding group therapy, was associated 
with positive effects in peer support and involvement in treatment, 
while increasing the individual’s probability to remain abstinent. 
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